Data / Drug companies / Focus Consumer Healthcare, LLC
Focus Consumer Healthcare, LLC: 11 products in the FDA NDC directory, labeler code 71687
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Focus Consumer Healthcare, LLC (labeler code 71687) lists 11 products in the FDA National Drug Code Directory, covering 10 finished drugs by generic name. By type: 11 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on January 23, 2026.
The request: Watch Focus Consumer Healthcare, LLC (FDA labeler code 71687): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 71687
- Products in commercial distribution
- 11
- Packages
- 15
- Finished drugs by generic name
- 10
- Prescription products
- 0
- Over the counter products
- 11
- Flagged as original packager
- 11 of 11 products that carry the flag
- Started marketing in the last 12 months
- 2
- Products with a marketing end date set
- 1
- Earliest marketing start
- June 1, 2016
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 11 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 11 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Acetaminophen, pamabrom, pyrilamine maleate | 1 | 13 |
| Allantoin, benzethonium chloride, lidocaine hcl | 1 | 1 |
| Pamabrom | 1 | 7 |
| Zinc oxide, dimethicone | 1 | 3 |
| Salicylic acid | 1 | 330 |
| Acetaminophen and pamabrom and pyrilamine maleate | 1 | 1 |
| Acetaminophen and aspirin and caffeine | 1 | 2 |
| Benzocaine | 1 | 110 |
| Camphor | 1 | 23 |
| Benzoyl peroxide | 1 | 82 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Gel | 3 | 27.3% |
| Tablet | 2 | 18.2% |
| Tablet, film coated | 2 | 18.2% |
| Stick | 2 | 18.2% |
| Cream | 1 | 9.1% |
| Ointment | 1 | 9.1% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Amide Local Anesthetic | 1 |
| Antiarrhythmic | 1 |
| Central Nervous System Stimulant | 1 |
| Methylxanthine | 1 |
| Nonsteroidal Anti-inflammatory Drug | 1 |
| Platelet Aggregation Inhibitor | 1 |
| Standardized Chemical Allergen | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Herpecin L | 71687-7774 | Stick | Over the counter monograph drugs | January 23, 2026 |
| Pamprin Bloat | 71687-3009 | Tablet, film coated | Over the counter monograph drugs | December 31, 2025 |
| Herpecin Pain Relief | 71687-4000 | Gel | Over the counter monograph drugs | June 11, 2021 |
| Zapzyt Acne Treatment Gel | 71687-0011 | Gel | Over the counter monograph drugs | December 16, 2017 |
| Zapzyt Acne Wash Cleanser | 71687-0007 | Gel | Over the counter monograph drugs | December 16, 2017 |
| Benzodent | 71687-1053 | Cream | Over the counter monograph drugs | December 8, 2017 |
| Pamprin Max Menstrual Pain Relief | 71687-3006 | Tablet, film coated | Over the counter monograph drugs | October 18, 2017 |
| Herpecin L | 71687-7773 | Stick | Over the counter monograph drugs | October 13, 2017 |
| Premsyn pms Premenstrual Pain Relief | 71687-3102 | Tablet | Over the counter monograph drugs | October 13, 2017 |
| Blue Star Medicated | 71687-2010 | Ointment | Over the counter monograph drugs | October 13, 2017 |
| Pamprin Multi-Symptom Maximum Strength | 71687-3003 | Tablet | Over the counter monograph drugs | June 1, 2016 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.